CME vs SLNO · P/E 22, rev $3.59B vs P/E 27, $2.76B cap
CME Group Inc (CME) versus Soleno Therapeutics Inc (SLNO) — a side-by-side from cached financials, not a winner call.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Soleno Therapeutics Inc (SLNO) is a biotechnology company listed on NASDAQ.
Latest reported CME revenue for 2026-06-30 was $3.59B. Net income was $2.20B. Revenue was up 90.8% from 2026-03-31 to 2026-06-30. CME currently screens at market cap $91.25B and trailing P/E 21.9.
SLNO does not have a complete income-statement cache yet.
CME currently screens at market cap $91.25B and trailing P/E 21.9. SLNO currently screens at market cap $2.76B and trailing P/E 27.5.
Not investment advice. Open the CME and SLNO stock pages for the full models.
Not investment advice.